What is she best known for?
The fields of study she is best known for:
- Gene
- Immune system
- T cell
Jenny E. Gumperz spends much of her time researching Immunology, Molecular biology, MHC class I, Natural killer cell and Antigen.
Within one scientific family, Jenny E. Gumperz focuses on topics pertaining to Cytotoxic T cell under Immunology, and may sometimes address concerns connected to T cell.
Her work deals with themes such as HLA-B Antigens and HLA-C, which intersect with Molecular biology.
Her research in Natural killer cell intersects with topics in Interleukin 21 and Human leukocyte antigen.
Her is involved in several facets of Antigen study, as is seen by her studies on CD1D and Natural killer T cell.
Her work carried out in the field of CD1D brings together such families of science as Interleukin 12 and Transfection.
Her most cited work include:
- Functionally Distinct Subsets of CD1d-restricted Natural Killer T Cells Revealed by CD1d Tetramer Staining (664 citations)
- Mechanism of CD1d-restricted natural killer T cell activation during microbial infection (608 citations)
- The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor (452 citations)
What are the main themes of her work throughout her whole career to date?
Her primary scientific interests are in Natural killer T cell, Cell biology, Immunology, CD1D and Antigen.
Her Natural killer T cell research includes elements of Secretion, Interleukin 12, Immune tolerance and MHC class II.
Jenny E. Gumperz interconnects T cell, Antigen-presenting cell, CD1, Cytokine secretion and Interleukin 2 in the investigation of issues within Cell biology.
Her Immunology research is multidisciplinary, incorporating elements of Natural killer cell and Haematopoiesis.
Jenny E. Gumperz has included themes like Glycolipid, Monocyte, Antigen presentation and Interleukin 4 in her CD1D study.
Her Antigen research integrates issues from Cell, Biochemistry, Immune system, Microbiology and Molecular biology.
She most often published in these fields:
- Natural killer T cell (39.18%)
- Cell biology (36.08%)
- Immunology (32.99%)
What were the highlights of her more recent work (between 2012-2020)?
- Immunology (32.99%)
- B cell (8.25%)
- Cell biology (36.08%)
In recent papers she was focusing on the following fields of study:
The scientist’s investigation covers issues in Immunology, B cell, Cell biology, Epstein–Barr virus and T cell.
Her Immunology research is multidisciplinary, incorporating perspectives in Haematopoiesis and Transplantation.
Her studies deal with areas such as Cell and CD1 as well as B cell.
Jenny E. Gumperz combines subjects such as Natural killer T cell, CD1D, Secretion, Cytokine secretion and Inflammation with her study of Cell biology.
Her Natural killer T cell research includes themes of Interleukin 2 and Signal transduction.
Her biological study spans a wide range of topics, including Humanized mouse and Cytotoxic T cell.
Between 2012 and 2020, her most popular works were:
- PD-1/CTLA-4 Blockade Inhibits Epstein-Barr Virus-Induced Lymphoma Growth in a Cord Blood Humanized-Mouse Model (57 citations)
- LMP1-deficient Epstein-Barr virus mutant requires T cells for lymphomagenesis. (47 citations)
- Mice Engrafted with Human Fetal Thymic Tissue and Hematopoietic Stem Cells Develop Pathology Resembling Chronic Graft-versus-Host Disease (35 citations)
In her most recent research, the most cited papers focused on:
- Gene
- Immune system
- T cell
Jenny E. Gumperz mainly investigates Immunology, B cell, Cytotoxic T cell, Immune system and T cell.
Jenny E. Gumperz has researched Immunology in several fields, including In vivo and Cytolysis.
Her B cell study which covers Cancer research that intersects with CD1, Humanized mouse, Virus latency, Cord blood and Virology.
Her Cytotoxic T cell research is multidisciplinary, relying on both Jurkat cells, Regulation of gene expression, Transcriptional regulation and Molecular biology.
Her Immune system study incorporates themes from Ductal carcinoma, Breast carcinoma, Carcinoma and Cytokine.
Her study in T cell is interdisciplinary in nature, drawing from both NSG mouse and Activator.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
